UnitedHealth Group (NYSE:UNH) PT Raised to $310.00

Share on StockTwits

UnitedHealth Group (NYSE:UNH) had its target price raised by analysts at BMO Capital Markets to $310.00 in a research note issued on Wednesday, The Fly reports. The firm presently has a “market perform” rating on the healthcare conglomerate’s stock. BMO Capital Markets’ price target would indicate a potential upside of 11.95% from the company’s current price.

A number of other equities research analysts also recently issued reports on the company. Credit Suisse Group restated an “outperform” rating and set a $320.00 price objective (up from $293.00) on shares of UnitedHealth Group in a research report on Wednesday. Cantor Fitzgerald increased their price target on UnitedHealth Group from $310.00 to $315.00 in a report on Wednesday. SunTrust Banks restated a “buy” rating and set a $335.00 price target (up previously from $310.00) on shares of UnitedHealth Group in a report on Monday, November 18th. Wells Fargo & Co raised their price target on UnitedHealth Group from $288.00 to $318.00 and gave the stock an “in-line” rating in a research report on Wednesday. Finally, Barclays increased their target price on shares of UnitedHealth Group from $260.00 to $305.00 and gave the company an “overweight” rating in a research note on Monday. Six research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of $297.25.

UNH stock opened at $276.90 on Wednesday. The company has a fifty day simple moving average of $259.15 and a two-hundred day simple moving average of $245.54. UnitedHealth Group has a 52 week low of $208.07 and a 52 week high of $287.94. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.67. The firm has a market capitalization of $265.15 billion, a P/E ratio of 21.50, a price-to-earnings-growth ratio of 1.48 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $3.88 EPS for the quarter, beating the Zacks’ consensus estimate of $3.75 by $0.13. The firm had revenue of $60.35 billion during the quarter, compared to the consensus estimate of $59.84 billion. UnitedHealth Group had a net margin of 5.57% and a return on equity of 25.30%. The firm’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same quarter last year, the firm earned $3.41 EPS. As a group, analysts anticipate that UnitedHealth Group will post 14.96 EPS for the current year.

In related news, Director Richard T. Burke sold 25,000 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, October 16th. The shares were sold at an average price of $236.56, for a total value of $5,914,000.00. Following the completion of the sale, the director now directly owns 163,331 shares in the company, valued at approximately $38,637,581.36. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP D Ellen Wilson sold 7,400 shares of the business’s stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $272.77, for a total transaction of $2,018,498.00. Insiders have sold 38,577 shares of company stock worth $9,398,080 in the last 90 days. Insiders own 0.82% of the company’s stock.

Hedge funds have recently made changes to their positions in the company. Garrison Point Advisors LLC increased its holdings in shares of UnitedHealth Group by 1.2% during the 2nd quarter. Garrison Point Advisors LLC now owns 3,486 shares of the healthcare conglomerate’s stock valued at $851,000 after purchasing an additional 40 shares in the last quarter. Clear Harbor Asset Management LLC increased its holdings in UnitedHealth Group by 0.6% in the third quarter. Clear Harbor Asset Management LLC now owns 6,573 shares of the healthcare conglomerate’s stock valued at $1,428,000 after buying an additional 40 shares in the last quarter. Smith Moore & CO. increased its holdings in UnitedHealth Group by 1.3% in the second quarter. Smith Moore & CO. now owns 3,156 shares of the healthcare conglomerate’s stock valued at $770,000 after buying an additional 41 shares in the last quarter. Cleararc Capital Inc. increased its holdings in UnitedHealth Group by 0.3% in the third quarter. Cleararc Capital Inc. now owns 12,943 shares of the healthcare conglomerate’s stock valued at $2,813,000 after buying an additional 42 shares in the last quarter. Finally, Empirical Finance LLC raised its position in shares of UnitedHealth Group by 1.9% in the third quarter. Empirical Finance LLC now owns 2,313 shares of the healthcare conglomerate’s stock worth $503,000 after acquiring an additional 43 shares during the period. 85.50% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Article: Retained Earnings

The Fly

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.